Forschen für das Leben
Georg-Speyer-Haus. Foto: Andreas Reeg, Tel: +40-171-5449247,,
Georg-Speyer-Haus. Foto: Andreas Reeg, Tel: +40-171-5449247,,
Georg-Speyer-Haus. Foto: Andreas Reeg, Tel: +40-171-5449247,,
Georg-Speyer-Haus. Foto: Andreas Reeg, Tel: +40-171-5449247,,

Tahmineh Darvishi

Tahmineh Darvishi has obtained her Diploma in Biology in 2003 from the Goethe University Frankfurt am Main. During her previous work at the Georg-Speyer-Haus as a research technician in the lab of Professor Groner she gathered experience in various molecular and cell-culture techniques. Currently as Lab Manager Tahmineh is in charge of experimental projects and duties for the lab of Dr. Farin.

Constantin Menche

Constantin Menche has studied Molecular Medicine at Goethe University Frankfurt am Main and worked in his master thesis on the plasticity of colonic epithelial stem cells as well as the establishment of efficient gene targeting methods. In 2017 he has started his PhD on the role of stromal Zeb1 during CRC progression, that is part of the DFG research group FOR 2438: Cell Plasticity in Colorectal Carcinogenesis.

Dr. Mohammed Mosa

Dr. Mohammed Mosa obtained his master degree in 2014 from the KU Leuven at the Lab of Massimiliano Mazzone (Belgium). In 2019 he passed his PhD in GSH research group on the topic Role of Wnt Signaling in the Tumor Microenvironment of Colorectal Cancer. Mohammed is employed as a Staff Scientist for the Frankfurt Cancer Institute (FCI) coordinating the development of patient-derived organoid models. He is also associated with the EU-project EUbOPEN for pharmacological testing of colorectal cancer models.

Dr. Benardina Ndreshkjana

Dr. Benardina Ndreshkjana graduated in pharmacy at the University of Milan (Italy) and holds a PhD from University Hospital Erlangen. Headed by Prof. Dr. rer. nat. Regine Schneider-Stock in the Department of Experimental Tumor Pathology, Benardina analyzed mechanisms to overcome chemoresistance. Her research at GSH is funded by the EU-project (IMI2) EUbOPEN and aims to understand drug-resistance mechanisms in patient-derived tumor organoids.

Dr. med. Christian Issing

Dr. med. Christian Issing is a resident at the Department of Otorhinolaryngology, Medical University Frankfurt and he obtained his MD in 2021 on a research project on clinical improvement of cochlear implant therapy. Christian has joined the group in 2020 as clinician scientist on a project on derivation and characterization of organoids of head and neck tumors. His project is funded by the Frankfurt Cancer Institute and the Mildred-Scheel-Nachwuchszentrum (MSNZ) program and aims to develop new preclinical tumor models.

Alena Kress

Alena Kress has studied Biological Sciences at the University of Konstanz, where she absolved her Master project on the characterization of phagocytic receptors for the recognition and elimination of pathogenic bacteria in the lab of Prof. Christof Hauck (Department Cell Biology). She has joined the lab in 2021 and her current PhD project addresses immune-epithelial interactions in the colon cancer microenvironment.

Sara Stier

Sara Stier has obtained an education as research technician in Wiesbaden and subsequently studied biology at the Technical University of Darmstadt where she obtained her Bachelor degree. At GSH she has jointed the team to develop drug-screening assays as part of the EU-project EUbOPEN.